You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
無視風險提示 九安醫療(002432.SZ)再度漲停創逾6年新高 最近1個月累漲400%
格隆匯 12-21 09:51
格隆匯12月21日丨自11月中旬以來啟動上漲行情的九安醫療(002432.SZ)無視昨晚的風險提示,今日盤中再度漲停,報34.51元,股價創逾6年新高,最新市值165億元。該股資金7個交易日出現6個漲停板,且從11月13日上漲至今,最近1個月累計漲幅超400%。此前公司在互動易平台透露試劑盒獲得美國FDA EUA授權,股價由此開啟暴漲模式。由於此消息在互動易平台答覆的時間早於在指定媒體披露的時間,公司一度收深交所監管函。公司昨晚發佈異動公吿稱,子公司的新冠抗原家用自測OTC試劑盒在海外銷售收入和疫情的發展密切相關,因疫情發展的不可預見性、疫苗接種計劃的推進、產品應急使用授權(EUA)有效期,以及市場的發展和變化等多方面因素的影響,該產品獲得美國應急使用授權(EUA)後,公司目前尚無法預測未來由該產品給公司營業收入和業績帶來的影響。互動易問答中説明的產能為生產能力,無法由此推斷實際產量,更無法推斷出實際銷量。非由公司發佈的信息(包括但不限於生產、銷售等相關情況)不代表公司立場。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account